Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 3
Submit an article Journal homepage
378
Views
17
CrossRef citations to date
0
Altmetric
Research Article

CD19 Expression and Growth Inhibition of Tumours in Human Multiple Myeloma

Hideaki Ishikawa Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Naohiro Tsuyama Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Maged S. Mahmoud Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Ryuichi Fujii Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Saeid Abroun Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Shangqin Liu Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
,
Fu-Jun Li Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
&
Michio M. Kawano Department of Bio-Signal Analysis, Applied Medical Engineering Science, Graduate School of Medicine, Yamaguchi University, 1-1-1 Minami-kogushi, Ube, Yamaguchi 755-8505, Japan
 show all
Pages 613-616 | Published online: 01 Jul 2009

Citations (17)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Saar Gill & David L Porter. (2014) CAR-modified anti-CD19 T cells for the treatment of B-cell malignancies: rules of the road. Expert Opinion on Biological Therapy 14:1, pages 37-49.
Read now

Articles from other publishers (16)

Rujul H. Parikh & Sagar Lonial. (2023) Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice. CA: A Cancer Journal for Clinicians 73:3, pages 275-285.
Crossref
Koya Ito, Masashi Ohe, Haruki Shida, Katsura Nagai, Ken Furuya & Tetsuro Okamoto. (2022) Multiple myeloma diagnosed by flow cytometry plotting of CD19-positive and negative plasma cells. Journal of Clinical and Experimental Investigations 13:4, pages em00802.
Crossref
Mihaiela L. Dragoș, Iuliu C. Ivanov, Mihaela Mențel, Irina C. Văcărean-Trandafir, Adriana Sireteanu, Amalia A. Titianu, Angela S. Dăscălescu, Alexandru B. Stache, Daniela Jitaru & Dragoș L. Gorgan. (2022) Prognostic Value of Association of Copy Number Alterations and Cell-Surface Expression Markers in Newly Diagnosed Multiple Myeloma Patients. International Journal of Molecular Sciences 23:14, pages 7530.
Crossref
David Kegyes, Catalin Constantinescu, Louise Vrancken, Leo Rasche, Celine Gregoire, Bogdan Tigu, Diana Gulei, Delia Dima, Alina Tanase, Hermann Einsele, Stefan Ciurea, Ciprian Tomuleasa & Jo Caers. (2022) Patient selection for CAR T or BiTE therapy in multiple myeloma: Which treatment for each patient?. Journal of Hematology & Oncology 15:1.
Crossref
Mashhour Hosny, Christie P. M. Verkleij, Jort van der Schans, Kristine A. Frerichs, Tuna Mutis, Sonja Zweegman & Niels W. C. J. van de Donk. (2021) Current State of the Art and Prospects of T Cell-Redirecting Bispecific Antibodies in Multiple Myeloma. Journal of Clinical Medicine 10:19, pages 4593.
Crossref
Fabio NICOLINI, Sara BRAVACCINI, Massimiliano MAZZA, Alicja M. GRUSZKA, Marcella TAZZARI, Beatriz MARTÍN-ANTONIO, Manel JUAN, Toni IBRAHIM, Roberta MALTONI, Giovanni MARTINELLI & Claudio CERCHIONE. (2021) CAR T cells targeting options in the fight against multiple myeloma. Panminerva Medica 63:1.
Crossref
Estefanía García-Guerrero, Belén Sierro-Martínez & Jose Antonio Pérez-Simón. (2020) Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma. Frontiers in Immunology 11.
Crossref
Chiara Caraccio, Sachi Krishna, Darci J. Phillips & Christian M. Schürch. (2020) Bispecific Antibodies for Multiple Myeloma: A Review of Targets, Drugs, Clinical Trials, and Future Directions. Frontiers in Immunology 11.
Crossref
Daniel Feinberg, Barry Paul & Yubin Kang. (2019) The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma. Cellular Immunology 345, pages 103964.
Crossref
Derrick R. Samuelson, Nicholas M. de la Rua, Tysheena P. Charles, Sanbao Ruan, Christopher M. Taylor, Eugene E. Blanchard, Meng Luo, Alistair J. Ramsay, Judd E. Shellito & David A. Welsh. (2016) Oral Immunization of Mice with Live Pneumocystis murina Protects against Pneumocystis Pneumonia . The Journal of Immunology 196:6, pages 2655-2665.
Crossref
Saeid Abroun, Najmaldin Saki, Rahim Fakher & Farahnaz Asghari. (2012) Biology and Bioinformatics of Myeloma Cell. Laboratory Hematology 18:4, pages 30-41.
Crossref
Kemeng Wang, Guoqing Wei & Delong Liu. (2012) CD19: a biomarker for B cell development, lymphoma diagnosis and therapy. Experimental Hematology & Oncology 1:1.
Crossref
Qi-Ming Yu, Chuan-Ding Yu & Zhi-Qiang Ling. (2012) Elevated Circulating CD19 + Lymphocytes Predict Survival Advantage in Patients with Gastric Cancer . Asian Pacific Journal of Cancer Prevention 13:5, pages 2219-2224.
Crossref
Jonathan Zalevsky, Irene W. L. Leung, Sher Karki, Seung Y. Chu, Eugene A. Zhukovsky, John R. Desjarlais, David F. Carmichael & Chris E. Lawrence. (2009) The impact of Fc engineering on an anti-CD19 antibody: increased Fcγ receptor affinity enhances B-cell clearing in nonhuman primates. Blood 113:16, pages 3735-3743.
Crossref
Hidetaka Niizuma, Kunihiro Fujii, Atsushi Sato, Ikuma Fujiwara, Junji Takeyama & Masue Imaizumi. (2006) PTHrP‐independent hypercalcemia with increased proinflammatory cytokines and bone resorption in two children with CD19‐negative precursor B acute lymphoblastic leukemia. Pediatric Blood & Cancer 49:7, pages 990-993.
Crossref
Bernd Schlereth, Cornelia Quadt, Torsten Dreier, Peter Kufer, Grit Lorenczewski, Nadja Prang, Christian Brandl, Sandra Lippold, Kathy Cobb, Kathleen Brasky, Eugen Leo, Ralf Bargou, Krishna Murthy & Patrick A. Baeuerle. (2005) T-cell activation and B-cell depletion in chimpanzees treated with a bispecific anti-CD19/anti-CD3 single-chain antibody construct. Cancer Immunology, Immunotherapy 55:5, pages 503-514.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.